Echinococcus multilocularis: microsatellite polymorphism in U1 snRNA genes.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 8631384)

Published in Exp Parasitol on April 01, 1996

Authors

S Bretagne1, B Assouline, D Vidaud, R Houin, M Vidaud

Author Affiliations

1: Laboratoire de Parasitologie, Faculté de Médecine, Université de Paris XII, Créteil, France.

Articles by these authors

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (1999) 5.55

Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res (1999) 4.74

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med (1994) 2.94

Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer (1998) 2.52

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology (2001) 2.41

Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol (1995) 2.28

Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J Infect Dis (1993) 2.04

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut (2007) 1.98

Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology (1999) 1.94

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res (1998) 1.80

Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem (1999) 1.74

Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res (2001) 1.72

Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial Western Blot. J Clin Microbiol (2000) 1.62

Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59

Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol (2001) 1.58

Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut (2009) 1.56

Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia (2000) 1.55

Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics (1992) 1.53

Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res (2000) 1.53

A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia. Proc Natl Acad Sci U S A (1989) 1.48

TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem (1999) 1.48

Cutaneous leishmaniasis of humans due to Leishmania (Viannia) naiffi outside Brazil. Trans R Soc Trop Med Hyg (1996) 1.46

Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res (2001) 1.45

PCR enzyme-linked immunosorbent assay for diagnosis of leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol (1996) 1.42

Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J (1991) 1.40

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology (1998) 1.37

Detection of Echinococcus multilocularis DNA in fox faeces using DNA amplification. Parasitology (1993) 1.32

Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet (1996) 1.31

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene (2001) 1.29

SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet (2009) 1.28

Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest (2001) 1.27

Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics (1989) 1.26

Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology (1997) 1.24

Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum. J Microbiol Methods (2001) 1.24

Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene. Eur J Hum Genet (1993) 1.24

Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A (1986) 1.23

Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol (1990) 1.17

Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies. Experientia (1984) 1.15

Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. Carcinogenesis (2001) 1.14

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology (1999) 1.14

Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol (1996) 1.13

Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metab (2000) 1.12

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut (2003) 1.11

Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res (1990) 1.10

Microsatellite in the beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screening of amniotic fluids. J Clin Microbiol (1997) 1.10

Tinea capitis in adults: misdiagnosis or reappearance? Dermatology (1997) 1.10

Gene expression and hepatitis C virus infection. Gut (2008) 1.08

Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene (1993) 1.07

Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrob Agents Chemother (1997) 1.07

VJ rearrangements of the TCR gamma locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. J Pathol (1996) 1.07

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer (2002) 1.06

Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopathology (2003) 1.03

The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII gene. Blood (1990) 1.03

Clonal analysis of renal sporadic angiomyolipomas. Hum Pathol (1998) 1.02

The peculiar spectrum of beta-thalassemia genes in Tunisia. Hum Genet (1988) 1.02

Cellular immunity in experimental Echinococcus multilocularis infection. I. Sequential and comparative study of specific in vivo delayed-type hypersensitivity against E. multilocularis antigens in resistant and sensitive mice. Clin Exp Immunol (1990) 1.02

Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid (2001) 1.01

Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol (2001) 1.01

Improved DNA markers for efficient analysis of fragile X families. Am J Med Genet (1988) 1.00

Prenatal detection by real-time quantitative PCR and characterization of a new CFTR deletion, 3600+15kbdel5.3kb (or CFTRdele19). Clin Chem (2000) 0.98

Mouse alpha chains inhibit polymerization of hemoglobin induced by human beta S or beta S Antilles chains. Biochim Biophys Acta (1988) 0.98

Leishmaniasis in AIDS patients: results of leukocytoconcentration, a fast biological method of diagnosis. Bull World Health Organ (1996) 0.97

Determination of the spectrum of beta-thalassemia genes in Spain by use of dot-blot analysis of amplified beta-globin DNA. Am J Hum Genet (1988) 0.97

PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology (2001) 0.95

Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Transplant (1995) 0.95

XY sex reversal associated with a nonsense mutation in SRY. Genomics (1992) 0.94

Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite (1998) 0.94

Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy. Gut (2003) 0.93

Large variability of trophoblast gene expression within and between human normal term placentae. Placenta (2004) 0.93

[Ecology of leishmaniases in Southern France. 1. Phlebotomus. Sampling--ethology]. Ann Parasitol Hum Comp (1970) 0.93

htert expression correlates with MYC over-expression in human prostate cancer. Int J Cancer (2000) 0.92

Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob Agents Chemother (1998) 0.92

Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. Cancer Res (1997) 0.92

Arvicola terrestris an intermediate host of Echinococcus multilocularis in France: epidemiological consequences. Int J Parasitol (1982) 0.92

[Natural transmission of Schistosoma mansoni in Guadeloupe (French Antilles). Preliminary note (author's transl)]. Ann Parasitol Hum Comp (1977) 0.91

The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost (2006) 0.91

Clonal analysis of macronodules in cirrhosis. Hepatology (1998) 0.90

A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B. Blood (1986) 0.90

Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol (1995) 0.90

A comprehensive scanning method for rapid detection of beta-globin gene mutations and polymorphisms. Hum Mutat (1992) 0.89

Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model. Parasite (1997) 0.89